Molecular and Functional Differences Induced in Thrombospondin-1 by the Single Nucleotide Polymorphism Associated with the Risk of Premature, Familial Myocardial Infarction
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
A serine (Ser-700) amino acid rather than an asparagine (Asn-700) at residue 700 of thrombospondin-1 has been linked to an increased risk for development of premature, familial heart attacks. We now have identified both functional and structural differences between the Ser-700 and Asn-700 thrombospondin-1 variants. The Ser-700 variant increased the rate and extent of platelet aggregation and showed increased surface expression on platelets compared with the Asn-700 variant. These differences could be ascribed to an enhanced interaction of the Ser-700 variant with fibrinogen on the platelet surface and are consistent with a prothrombotic phenotype in Ser-700 individuals. The Ser-700 variant thrombospondin-1 was conformationally more labile than the Asn-700 variant as demonstrated by increased susceptibility to proteolytic digestion and enhanced susceptibility to unfolding by denaturants. These data suggest a potential molecular and cellular basis for a genetic risk factor associated with early onset myocardial infarction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Substitution of serine lowers calcium binding capacity decreasing TSP1 conformational stability but enhancing platelet aggregation [15, 48, 49].”
From Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients (2024) · cites this paper as [49]
In the citing paper
“In SNP rs2228262, changing A to G results in an amino acid change (asparagine to serine) in the calcium binding domain significantly impacts TSP1 structure and function.”
From Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients (2024) · cites this paper as [49]
Citations
Cites
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness
Van Eerdewegh, P., Little, R. D., Dupuis, J., Del Mastro, R. G., Falls, K., Simon, J., Torrey, D., Pandit, S., McKenny, J., Braunschweiger, K., et al. (2002) · Nature · doi:10.1038/nature00878 · Cited by 1,099
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. (2003) · Nature Medicine · doi:10.1038/nm810 · Cited by 1,005
A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation
Massberg, S., Brand, K., Grüner, S., Page, S., Müller, E., Müller, I., Bergmeier, W., Richter, T., Lorenz, M., Konrad, I., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012044 · Cited by 879
Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V., & Bainton, D. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.880 · Cited by 871
Human platelets possess an inducible and saturable receptor specific for fibrinogen.
Marguerie, G. A., Plow, E. F., & Edgington, T. S. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50603-7 · Cited by 706
Self-citationStryer, L. (1968) · Science · doi:10.1126/science.162.3853.526 · Cited by 705
Weiss, E. J., Bray, P. F., Tayback, M., Schulman, S. P., Kickler, T. S., Becker, L. C., Weiss, J. L., Gerstenblith, G., & Goldschmidt-Clermont, P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341703 · Cited by 689
Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate Genes
Yamada, Y., Izawa, H., Ichihara, S., Takatsu, F., Ishihara, H., Hirayama, H., Sone, T., Tanaka, M., & Yokota, M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021445 · Cited by 640
Research works printed but not linked: 1
- Peyvandi, 2003, Blood, 102, 11
Cited by
Adams, J. C., & Lawler, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009712 · Cited by 457
“Nevertheless, biochemical and cellular analyses of the N700S and A387P SNPs of TSP-1 and TSP-4, respectively, have identified effects on calcium binding, protein conformation, and interactions with cells and ECM components of the vessel wall and platelet clot (Stenina et al. 2003, 2005; Narizhneva et al. 2004; Carlson…”
BackgroundMatricellular Proteins in Cardiac Adaptation and Disease
Frangogiannis, N. G. (2012) · Physiological Reviews · doi:10.1152/physrev.00008.2011 · Cited by 445
“A recent investigation demonstrated that the Ser-700 TSP-1 variant increased the rate and extent of platelet aggregation and showed increased surface expression on platelets compared with the Asn-700 variant (319).”
BackgroundInflammation and metabolic dysfunction: links to cardiovascular diseases
Taube, A., Schlich, R., Sell, H., Eckardt, K., & Eckel, J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00907.2011 · Cited by 238
“Experimental data have shown that TSP-1 stimulates the aggregation and stability of platelet aggregates (188), induces the expression of cell adhesion molecules (189) in endothelial cells, and stimulates chemotaxis in vascular SMCs (147, 191).”
BackgroundThrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses
ISENBERG, J., WINK, D., & ROBERTS, D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.024 · Cited by 132
“Furthermore, a structural polymorphism in TSP1 increases the risk of premature, familial myocardial infarction [49], but the activity of this TSP1 variant to inhibit NO signaling remains to be determined.”
BackgroundPathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork‐A review
Keller, K. E., & Peters, D. M. (2022) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14027 · Cited by 137
Thrombospondins: from structure to therapeutics
Bonnefoy, A., de Moura, R. J., & Hoylaerts, M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7487-y · Cited by 94
Rogers, N. M., Sharifi‐Sanjani, M., Csányi, G., Pagano, P. J., & Isenberg, J. S. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.01.002 · Cited by 100
“Replacement of an asparagine residue with a serine at residue 700 of TSP1 led to a protein variant that, in cell culture experiments, promoted pro-thrombotic phenomena, including augmented fibrinogen binding and enhanced platelet aggregation (Narizhneva et al. 2004).”
BackgroundThe effect of genetic diversity on angiogenesis
Rogers, M. S., & D’Amato, R. J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.021 · Cited by 73
The role of thrombospondin-1 in cardiovascular health and pathology
Krishna, S. M., & Golledge, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.139 · Cited by 75
“Adhesion of leucocytes to ECs is augmented by TSP-1 inducing the cell surface expression of various adhesion molecules [60].”
BackgroundThrombospondins, Their Polymorphisms, and Cardiovascular Disease
Stenina‐Adognravi, O., Topol, E. J., & Plow, E. F. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.141713 · Cited by 66
Self-citationThrombospondin-1 in maladaptive aging responses: a concept whose time has come
Isenberg, J. S., & Roberts, D. D. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00089.2020 · Cited by 51
Zwicker, J. I. (2006) · Blood · doi:10.1182/blood-2006-04-015701 · Cited by 51
Voora, D., Horton, J., Shah, S. H., Shaw, L. K., & Newby, L. K. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.03.026 · Cited by 44
TSP1 and MMP9 genetic variants in sporadic prostate cancer
Sfar, S., Saad, H., Mosbah, F., Gabbouj, S., & Chouchane, L. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.07.014 · Cited by 43
Hannah, B.-L. A., Misenheimer, T. M., Pranghofer, M. M., & Mosher, D. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409632200 · Cited by 40
Koch, W., Hoppmann, P., de Waha, A., Schömig, A., & Kastrati, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn001 · Cited by 45
Polymorphisms A387P in thrombospondin‐4 and N700S in thrombospondin‐1 perturb calcium binding sites
Stenina‐Adognravi, O., Ustinov, V., Krukovets, I., Marinic, T. E., Topol, E. J., & Plow, E. F. (2005) · The FASEB Journal · doi:10.1096/fj.05-3712fje · Cited by 39
“These changes in protein stability are associated with an increased capacity of the S700 variant to support platelet aggregation, a potential mechanism for its prothrombotic activity (10).”
BackgroundResultSelf-citationO’Halloran, A. M., Patterson, C. C., Horan, P., Maree, A. O., Curtin, R. J., Stanton, A. V., McKeown, P., & Shields, D. C. (2008) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-008-0196-z · Cited by 37
“AA 76.9 76.4 75.2 76.7 700S is thermolabile and protein levels are reduced in plasma [ 33 , 34] 1.04 (0.79‐1.37) 0.78”
InfluentialRogers, N. M., Seeger, F., Garcin, E. D., Roberts, D. D., & Isenberg, J. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00134 · Cited by 45
“…dimensional structure of sGC is unknown but crystal structures of individual domains or domain homologs have been determined for the HNOX domain (Nioche et al., 2004; Pellicena et al., 2004; Ma et al., 2007; Olea et al., 2008; Erbil et al., 2009; Martin et al., 2010; Olea et al., 2010; Weinert…”
BackgroundSfar, S., Saad, H., Mosbah, F., & Chouchane, L. (2007) · Molecular Biology Reports · doi:10.1007/s11033-007-9149-4 · Cited by 33
“repeats and alters conformation change of full-length TSP1 protein [49–51] that may increase susceptibility to proteolytic degradation [ 52 ].”
Roberts, D. D., Kaur, S., & Isenberg, J. S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7140 · Cited by 35
“However, in vitro studies indicated that treatment with 10 l g/ml of mutant N 700 S TSP1 enhanced platelet aggregation and surface binding compared with that of nonmutant TSP1, suggesting a gain of function, but was itself more susceptible to proteolysis (177).”
Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String Formation
Seif, K., Alidzanovic, L., Tischler, B., Ibrahim, N., Zagrapan, B., Rauscher, S., Salzmann, M., Hell, L., Mauracher, L., Budde, U., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1675229 · Cited by 29
Molecular Mechanisms of Myocardial Infarction
Jefferson, B. K., & Topol, E. J. (2005) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2005.02.002 · Cited by 30
Self-citationInfluences of the N700S Thrombospondin-1 Polymorphism on Protein Structure and Stability
Carlson, C. B., Liu, Y., Keck, J. L., & Mosher, D. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800223200 · Cited by 25
A functional variant in the thrombospondin-1 gene and the risk of small for gestational age infants
ANDRAWEERA, P. H., DEKKER, G. A., THOMPSON, S. D., NORTH, R. A., McCOWAN, L. M. E., & ROBERTS, C. T. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04494.x · Cited by 23
Forbes, T., Pauža, A. G., & Adams, J. C. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00251.2021 · Cited by 26
Calzada, M. J., Kuznetsova, S. A., Sipes, J. M., Rodrigues, R., Cashel, J. A., ANNIS, D., Mosher, D. F., & Roberts, D. D. (2008) · Matrix Biology · doi:10.1016/j.matbio.2007.12.002 · Cited by 22
“Conformation changes associated with the N700S polymorphism in TSP1 were also reported to alter heparin and fibrinogen binding (Narizhneva et al., 2004).”
BackgroundAshokKumar, M., Anbarasan, C., SaiBabu, R., Kuram, S., Raman, S. C., & Cherian, K. M. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.05.026 · Cited by 15
“Increased TSP-1 levels in arterialwall has been shown to accelerate atherosclerosis and restenosis by affecting either smooth muscle cells and/or endothelial cells, by promoting leukocyte adhesion through various adhesion molecules [27].”
BackgroundControlled extracellular proteolysis of thrombospondins
Carminati, L., Carlessi, E., Longhi, E., & Taraboletti, G. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.03.011 · Cited by 14
Frank, B., Burwinkel, B., Bermejo, J. L., Försti, A., Hemminki, K., Houlston, R. S., Mangold, E., Rahner, N., Friedl, W., Friedrichs, N., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.043 · Cited by 11
Afshar‐Kharghan, V., Vijayan, K. V., & Bray, P. F. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50776-x · Cited by 15
Valades-Mejía, M. G., Domínguez‐López, M. L., Chimal, J. L. A., Leaños‐Miranda, A., Majluf‐Cruz, A., & Isordia‐Salas, I. (2014) · PubMed · Cited by 10
Frazier, W. A., Isenberg, J. S., Kaur, S., & Roberts, D. D. (2010) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a002870.01 · Cited by 10
Interactions among Stalk Modules of Thrombospondin-1
Liu, Y., & Mosher, D. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035089 · Cited by 6
Where Do We Go for Atherothrombotic Disease Genetics?
Brand‐Herrmann, S. (2008) · Stroke · doi:10.1161/strokeaha.107.508515 · Cited by 6
Sorenson, C. M., Gurel, Z., Song, Y.-S., Peterson, K. D., Blodi, B. A., & Sheibani, N. (2024) · PLOS ONE · doi:10.1371/journal.pone.0297135 · Cited by 5
Tang, Y., Wang, Y., Wang, S., Wang, R., Xu, J., Peng, Y., Ding, L., Zhao, J., Zhou, G., Sun, S., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1293393 · Cited by 8
Molecular Genetics of Coronary Artery Disease and Myocardial Infarction
Marı́n-Garcı́a, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00007-x · Cited by 4
Thrombospondins: Conserved mediators and modulators of metazoan extracellular matrix
Adams, J. C. (2024) · International Journal of Experimental Pathology · doi:10.1111/iep.12517 · Cited by 4
“…of the SNP alleles on TSP structure and functions revealed that THBS1 rs2228262 (a2210g), which results in a coding variant within the first type 3 repeat, TSP1700S, impairs a high-affinity calcium-binding site, 56,57 and increases platelet aggregation relative to the common variant TSP1N700.”
Krishnan, P., Sampath, H. J., Trinh, V. N., & Parton, L. A. (2025) · Children · doi:10.3390/children12040424 · Cited by 2
Genetic Markers in Cardiovascular Disease
Sabatine, M. S. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-051-5_34 · Cited by 1
Genomics of Myocardial Infarction
Hubbard, C. A., & Topol, E. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00024-6
Self-citationProatherogenic crosstalk between adipose tissue and smooth muscle cells
Schlich, R. (2012)
The Immunogenetics of asthma exacerbations in children
Bizzintino, J. A. (2011) · UWA Profiles and Research Repository (UWA)
Genomics of Myocardial Infarction
Hubbard, C. A., & Topol, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00057-3
Self-citationTang, Y., Wang, Y., Wang, S., Wang, R., Xu, J., Peng, Y., Ding, L., Zhao, J., Zhou, G., Sun, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3261284/v1
Ischemia and Myocardial Infarction: A Post-Genomic Analysis
Marı́n-Garcı́a, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50009-7
Metadata
- Authors
- Narizhneva, N. V., Byers-Ward, V. J., Quinn, M. J., Zidar, F. J., Plow, E. F., Topol, E. J., & Byzova, T. V.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Topol, Eric J.
- Byzova, Tatiana V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 279
- Issue
- 20
- Pages
- 21651-21657
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC1459418
- OpenAlex
- W1993880593
- Cited by
- 47
- References
- 48
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 1 · 2014: 4 · 2013: 1 · 2012: 3
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5988 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL071625., R01HL071625)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombospondin-1, platelet aggregation, fibrinogen binding, prothrombotic phenotype, protein conformational stability, proteolytic susceptibility, genetic risk factors, platelet surface expression
- MeSH terms
- Asparagine, Circular Dichroism, Humans, Myocardial Infarction, Platelet Aggregation, Risk Factors, Serine, Genetic Variation, Thrombospondin 1, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.